Gazette.govt.nzPursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
| Product: | Lenvima |
| Active Ingredient: | Lenvatinib mesilate 4.9mg equivalent to lenvatinib 4mg |
| Dosage Form: | Capsule |
| New Zealand Sponsor: | Eisai New Zealand Limited |
| Manufacturers: | Eisai Co Limited, Kakamigahara-shi, Japan Patheon Inc, Mississauga, Canada |
| Product: | Lenvima |
| Active Ingredient: | Lenvatinib mesilate 12.25mg equivalent to lenvatinib 10mg |
| Dosage Form: | Capsule |
| New Zealand Sponsor: | Eisai New Zealand Limited |
| Manufacturers: | Eisai Co Limited, Kakamigahara-shi, Japan Patheon Inc, Mississauga, Canada |
| Product: | Oxycodone hydrochloride |
| Active Ingredient: | Oxycodone hydrochloride 10mg/mL |
| Dosage Form: | Solution for injection |
| New Zealand Sponsor: | Max Health Limited |
| Manufacturer: | HBM Pharma s.r.o, Martin, Slovakia |
| Product: | Oxycodone hydrochloride |
| Active Ingredient: | Oxycodone hydrochloride 50mg/mL |
| Dosage Form: | Solution for injection |
| New Zealand Sponsor: | Max Health Limited |
| Manufacturer: | HBM Pharma s.r.o, Martin, Slovakia |
Dated this 9th day of April 2020.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).